Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Roszik

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Oncotarget|May 12, 2016
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanomaLucas Goedert, Cristiano G Pereira, Jason Roszik, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Cell Death & Disease|February 5, 2022
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanomaYasunari Fukuda, Matias A Bustos, Sung-Nam Cho, et al.
Investigative Ophthalmology & Visual Science|October 10, 2019
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal MelanomaChandrani Chattopadhyay, Junna Oba, Jason Roszik, et al.
Journal of Global Oncology|September 23, 2018
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case ReportAnthony P Conley, Van Anh Trinh, Chrystia M Zobniw, et al.
Cell Death & Disease|May 2, 2022
Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanomaYasunari Fukuda, Matias A Bustos, Sung-Nam Cho, et al.
JCO Precision Oncology|July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With CancerKyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Correction: IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Oncotarget|May 12, 2016
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanomaLucas Goedert, Cristiano G Pereira, Jason Roszik, et al.
Cancer Research Communications|July 14, 2022
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer SurvivalJason Roszik, J Jack Lee, Yi-Hung Wu, et al.
Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.
Cell Death & Disease|February 5, 2022
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanomaYasunari Fukuda, Matias A Bustos, Sung-Nam Cho, et al.
Investigative Ophthalmology & Visual Science|October 10, 2019
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal MelanomaChandrani Chattopadhyay, Junna Oba, Jason Roszik, et al.
Journal of Global Oncology|September 23, 2018
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case ReportAnthony P Conley, Van Anh Trinh, Chrystia M Zobniw, et al.
Cell Death & Disease|May 2, 2022
Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanomaYasunari Fukuda, Matias A Bustos, Sung-Nam Cho, et al.
JCO Precision Oncology|July 21, 2022
Identification of <i>KRAS</i><sup></sup> Mutations in Circulating Tumor DNA in Patients With CancerKyaw Z Thein, Amadeo B Biter, Kimberly C Banks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2023
Correction: IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
Pageof 17